SEINDA
Latest round
- Series A
Last raised
- Jul 2023
Total raised
- Undisclosed
Investors
- 1
About SEINDA
Established in 2015, and based in Guangzhou, China, Shengyuan Medicine doing business named SEINDA, is a pharmaceutical company that engaged in production, and sales of ophthalmic medical devices and new drugs. Its production bases in Guangzhou, which a clean production workshop, a microorganism test laboratory, physical and chemical inspection laboratory, and warehousing facilities. Its products can be divided into ophthalmic point-of-care testing (POCT) product, Covid-19 antigen test product, new drugs for eyes diseases. The ophthalmic point-of-care testing (POCT) product include micro-capillary fluid collectors, fluid collectors POC test kits, and i-Immundx™ analyzer, which enable physicians to detect etiology of ocular disorders, and can quantitative measurements. New drugs pipelines include SY101 for myopia, SY201 for dry eye, and SY-301 for presbyopia.
Who invested in SEINDA
1 investor across 1 round
See all investors in SEINDA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 17, 2023
Amount
Undisclosed
Investors
Questions about SEINDA
Who invested in SEINDA?
SEINDA has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SEINDA raised?
SEINDA has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SEINDA last raise money?
SEINDA's most recent round on record is a Series A, in Jul 2023.
What does SEINDA do?
Established in 2015, and based in Guangzhou, China, Shengyuan Medicine doing business named SEINDA, is a pharmaceutical company that engaged in production, and sales of ophthalmic medical devices and new drugs.
Where is SEINDA headquartered?
SEINDA is headquartered in Guangzhou, China.
Which VCs invest in companies like SEINDA?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at SEINDA's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like SEINDA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.